|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Colorectal Cancer | |||||
| Head and Neck Cancer | |||||
| Kidney Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Carcinoma, Renal Cell | |||||
| Colorectal Neoplasms | |||||
| Head and Neck Neoplasms | |||||
| Kidney Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Adenocarcinoma | |||||
| Carcinoma | |||||
| Colonic Diseases | |||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Intestinal Diseases | |||||
| Intestinal Neoplasms | |||||
| Kidney Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Rectal Diseases | |||||
| Urogenital Neoplasms | |||||
| Urologic Diseases | |||||
| Urologic Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| CNGRC peptide-TNF alpha conjugate | |||||
| 5 | Sponsors listed in this trial | ||||
| European Organization for Research and Treatment of Cancer | |||||